sertraline has been researched along with Premenstrual Syndrome in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (29.73) | 18.2507 |
2000's | 21 (56.76) | 29.6817 |
2010's | 4 (10.81) | 24.3611 |
2020's | 1 (2.70) | 2.80 |
Authors | Studies |
---|---|
Epperson, CN; Grillon, C; Hantsoo, L; Johnson, R; Marks, J; Sammel, M | 1 |
Brownley, KA; Girdler, SS; McLeod, MN; Stout, AL | 1 |
Freeman, EW; Lin, H; Rickels, K; Sammel, MD; Sondheimer, SJ | 2 |
Gricar, J; Rendas-Baum, R; Wallenstein, GV; Yang, M | 1 |
Dobzhenko, MN; Shchepotin, IB; Zotov, AS | 1 |
Freeman, EW; Frye, CA; Martin, PA; Rickels, K; Smith, SS | 1 |
Bergeron, R; Cohen, L; Freeman, E; Halbreich, U; Stout, AL; Yonkers, KA | 1 |
Halbreich, U; Kahn, LS | 1 |
Freeman, EW; Polansky, M; Rickels, K; Sondheimer, SJ; Xiao, S | 1 |
Freeman, EW; Martin, PG; Rickels, K; Sondheimer, SJ | 1 |
Fayyad, R; Gillespie, JA; Pearlstein, T; Yonkers, KA | 2 |
Farfel, GM; Fayyad, R; Gillespie, JA; Kornstein, SG; Pearlstein, TB | 1 |
Anderson, S; Kratz, K; Poppen, B | 1 |
Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R | 1 |
Freeman, EW; Rickels, K; Sondheimer, SJ; Wittmaack, FM | 1 |
Brown, C; Freeman, E; Halbreich, U; Pearlstein, T; Yonkers, KA | 1 |
Yonkers, KA | 1 |
Brown, C; Endicott, J; Frank, E; Freeman, E; Halbreich, U; Harrison, W; Parry, B; Pearlstein, T; Severino, S; Stone, A; Stout, A; Yonkers, KA | 1 |
Halbreich, U; Smoller, JW | 1 |
Cohen, LS | 1 |
Benedek, DM; Howard, RS; Hurt, PH; Young, SA | 1 |
Evans, MF; Fernandes, O; Por, CP | 1 |
Diaz, S; Howard, M; Jain, N; Pearlstein, T; Zlotnick, C | 1 |
Arredondo, F; Freeman, EW; Kao, LC; Pollack, SE; Rickels, K; Sondheimer, SJ | 1 |
Freeman, EW; Polansky, M; Rickels, K; Sondheimer, SJ | 2 |
Batzar, ED; Brown, CS; Endicott, J; Frank, E; Freeman, EW; Halbreich, U; Harrison, WM; Haskett, RF; Pearlstein, TB; Stout, AL; Yonkers, KA | 1 |
Freeman, EW; Garcia-Espagna, B; Polansky, M; Sondheimer, SJ | 1 |
Steiner, M | 1 |
Pearlstein, T; Steiner, M | 1 |
Dierich, MP; Fuchs, D; Lass-Flörl, C; Ledochowski, M; Semenitz, E | 1 |
Lin, J; Thompson, DS | 1 |
Carr, M | 1 |
Gupta, S | 1 |
6 review(s) available for sertraline and Premenstrual Syndrome
Article | Year |
---|---|
[Selective serotonin reuptake inhibitors and mammary pathologies].
Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Luteal Phase; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2003 |
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2008 |
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbidity; Depressive Disorder; Diagnosis, Differential; Female; Humans; Mental Disorders; Panic Disorder; Piperazines; Premenstrual Syndrome; Psychotherapy; Risk Factors; Sertraline; Sodium Lactate; Triazoles | 1997 |
Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
Topics: Diagnosis, Differential; Female; Fluoxetine; Humans; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Terminology as Topic | 2000 |
Treating premenstrual dysphoric disorder using serotonin agents.
Topics: Female; Fluoxetine; Humans; Mood Disorders; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
18 trial(s) available for sertraline and Premenstrual Syndrome
Article | Year |
---|---|
Chromium supplementation for menstrual cycle-related mood symptoms.
Topics: Adult; Affect; Antidepressive Agents; Chromium; Dietary Supplements; Double-Blind Method; Female; Health; Humans; Menstrual Cycle; Middle Aged; Patient Satisfaction; Premenstrual Syndrome; Sertraline; Single-Blind Method; Trace Elements; Treatment Outcome; Young Adult | 2013 |
Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline.
Topics: Adolescent; Adult; Cost-Benefit Analysis; Double-Blind Method; Drug Administration Schedule; Drug Costs; Female; Follow-Up Studies; Humans; Long-Term Care; Luteal Phase; Premenstrual Syndrome; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Young Adult | 2009 |
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Desipramine; Double-Blind Method; Female; Gonadal Steroid Hormones; Humans; Pregnanolone; Premenstrual Syndrome; Sertraline; Severity of Illness Index; Treatment Outcome | 2002 |
Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
Topics: Adult; Affective Symptoms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Luteal Phase; Middle Aged; Premenstrual Syndrome; Probability; Prospective Studies; Reference Values; Sertraline; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2002 |
Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
Topics: Adolescent; Adult; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires | 2004 |
Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.
Topics: Adult; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Individuality; Luteal Phase; Personality Inventory; Premenstrual Syndrome; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Topics: Adult; Antidepressive Agents; Cohort Studies; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follicular Phase; Follow-Up Studies; Humans; Luteal Phase; Premenstrual Syndrome; Sertraline; Single-Blind Method; Substance Withdrawal Syndrome; Treatment Outcome | 2005 |
Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Luteal Phase; Middle Aged; Premenstrual Syndrome; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2006 |
Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.
Topics: 1-Naphthylamine; Adolescent; Adult; Depressive Disorder; Desipramine; Double-Blind Method; Female; Humans; Middle Aged; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 1996 |
Sertraline in the treatment of premenstrual dysphoric disorder.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Premenstrual Syndrome; Psychiatric Status Rating Scales; Sertraline | 1996 |
Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
Topics: 1-Naphthylamine; Adult; Analysis of Variance; Depression; Double-Blind Method; Efficiency; Female; Humans; Irritable Mood; Luteal Phase; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Social Adjustment | 1997 |
Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
Topics: 1-Naphthylamine; Adult; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Luteal Phase; Menstrual Cycle; Middle Aged; Placebos; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 1997 |
Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
Topics: 1-Naphthylamine; Adult; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Luteal Phase; Medical Records; Personality Inventory; Placebos; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires | 1998 |
Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant.
Topics: Adolescent; Adult; Antidepressive Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Desipramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Placebos; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
Topics: Adaptation, Psychological; Adult; Female; Follicular Phase; Health Status; Humans; Luteal Phase; Medical Records; Middle Aged; Placebos; Premenstrual Syndrome; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Social Adjustment; Treatment Outcome | 2000 |
Predictors of response to sertraline treatment of severe premenstrual syndromes.
Topics: Adolescent; Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Middle Aged; Multivariate Analysis; Placebos; Premenstrual Syndrome; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2000 |
Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes.
Topics: Adolescent; Adult; Antidepressive Agents; Contraceptives, Oral; Desipramine; Double-Blind Method; Drug Interactions; Female; Humans; Middle Aged; Polypharmacy; Premenstrual Syndrome; Sertraline; Severity of Illness Index | 2001 |
13 other study(ies) available for sertraline and Premenstrual Syndrome
Article | Year |
---|---|
Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder.
Topics: Anxiety; Anxiety Disorders; Female; Humans; Menstrual Cycle; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Sertraline | 2021 |
Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.
Topics: Androstenes; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Fluoxetine; Humans; Mineralocorticoid Receptor Antagonists; Models, Economic; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Clinical subtypes of premenstrual syndrome and responses to sertraline treatment.
Topics: Adolescent; Adult; Antidepressive Agents; Female; Humans; Middle Aged; Mood Disorders; Premenstrual Syndrome; Sertraline; Young Adult | 2011 |
A pilot naturalistic follow-up of extended sertraline treatment for severe premenstrual syndrome.
Topics: Adult; Chi-Square Distribution; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Middle Aged; Pilot Projects; Premenstrual Syndrome; Sertraline | 2004 |
Premenstrual dysphoric disorder: treatment with sertraline, neuropsychological effects, and flight status.
Topics: Adult; Antidepressive Agents; Aviation; Female; Humans; Military Personnel; Neuropsychological Tests; Premenstrual Syndrome; Sertraline | 2007 |
Sertraline for premenstrual dysphoric disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Is sertraline an effective therapy for premenstrual dysphoric disorder?
Topics: 1-Naphthylamine; Family Practice; Female; Humans; Premenstrual Syndrome; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
Interactive case challenge. Dysphoric disorders in women: a case of premenstrual syndrome.
Topics: Adult; Female; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Recognition of premenstrual dysphoric disorder and its treatment.
Topics: Adolescent; Adult; Female; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain | 2001 |
Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Selections from current literature. Treatments for premenstrual dysphoric disorder.
Topics: Affective Symptoms; Antidepressive Agents; Calcium; Female; Fluoxetine; Humans; Luteal Phase; Phytotherapy; Plant Preparations; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Vitex | 2001 |
Beyond premenstrual syndrome.
Topics: Adult; Antidepressive Agents; Drug Approval; Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; United States Food and Drug Administration | 2002 |